Parkinson's disease (PD) is a systemic disease clinically defined by the degeneration of 27 dopaminergic neurons in the brain. While alterations in the gut microbiome composition have 28 been reported in PD, their functional consequences remain unclear. Herein, we first analysed 29 the gut microbiome of patients and healthy controls by 16S rRNA gene sequencing of stool 30 samples from the Luxembourg Parkinson's study (n=147 typical PD cases, n=162 controls). 31
with age and BMI, respectively ( Figure 3C ). Taken together, these analyses suggest that 151 microbial abundances are shifted in PD cases and that also the effects of important covariates 152 were altered in PD, reflecting the systemic and complex nature of PD. 153 154 155 Figure 2: Boxplots of seven significantly changed species in PD versus controls 156 (FDR<0.05). Significance levels were determined using multivariable semi-parametrical 157 fractional regressions with the group variable (PD vs. control) as predictor of interest, including 158 age, gender, BMI, and technical variables (i.e., total read-counts and batch effect) as covariates. 159
FDR=false discovery rate. 160 Paraprevotella (global test on all interaction terms, FDR<0.05). For graphical assessment of 166 the interaction terms the z-transformed residual abundances are displayed after correction for 167 technical covariates (batch and read counts). D. The genus relative abundance of 168 Bifidobacterium was increased in patients reporting to be constipated (FDR<0.05). E. Genus 169 association with disease staging showed a decrease of relative abundance of Paraprevotella 170 and an increase of Bilophila genus over increasing Hoehn and Yahr scale values (FDR<0.05). 171
F. An increased score in motor symptoms (UPDRS III) was associated with an increased trend 172 in abundances of Flavonifractor and Peptococcus and a decreased trend in Paraprevotella 173 abundance (FDR<0.05). UPDRS=Unified Parkinson Rating Scale, BMI=body mass index, 174
FDR=false discovery rate. 175 176
Microbial abundances, medication intake, and constipation in PD 177
The Luxembourg Parkinson's study enrols patients of all stages of PD. Therefore, the 178 patients have considerable inter-individual variance in PD-related features, such as constipation 179 and intake of medication (Table 1) . We analysed whether these features had an impact the 180 microbiome composition in PD. In our data, we could not find any evidence for an effect of the 181 three medication types on the microbiome, i.e., levodopa, COMT inhibitors, or inhibitors, when correcting for multiple testing ( Supplementary Table 2 ). In contrast, 183 constipation, a prevalent non-motor symptom in PD patients (Lesser 2002) , was associated 184 with an increased abundance of Bifidobacterium, with a clear effect in constipated PD cases 185 ( Figure 3D ). However, since there were only ten constipated controls (Table 1) , these results 186 must be confirmed in larger cohorts. 187 188 189 staging, NMS, and UPDRS (Unified Parkinson Rating Scale) scores, and its subscales, was 192 associated with altered genus abundance. For the Hoehn and Yahr staging, Paraprevotella 193 showed a negative association and Bilophila showed a positive association, both of which were 194 significant after multiple testing ( Figure 3E ). For the UPDRS III subscale score (i.e., motor 195 symptoms, Table 1 ), three genera, being Peptococcus, Flavonifractor, and Paraprevotella, 196 survived correction for multiple testing ( Figure 3F ). In contrast, the other UPDRS subscales 197 and the NMS were not significantly associated with microbial changes, after correction for 198 multiple testing. Note that these analyses were performed while adjusting for disease duration. 199 When analysing the association pattern of disease duration, we found Lactobacillus positively 200 correlated with the disease duration (FDR<0.05, Supplementary Figure S1 ). In conclusion, our 201 data suggest that the microbial composition may be utilised as a correlate of disease severity. 202
203

Metabolic modelling reveals distinct metabolic secretion capabilities of PD microbiomes 204
To obtain insight into the possible functional consequence of observed microbiome 205 changes in PD, we used metabolic modelling (cf. Methods). Briefly, we mapped each of the 206 309 microbiome samples on the generic microbial community model consisting of 819 gut 207 microbial reconstructions (Magnusdottir et al. 2017; Heinken et al. 2019) (cf. Supplementary 208 Material) to derived personalised microbiome models (Baldini et al. 2018) . We then computed 209 a net maximal production capability (NMPC) for 129 different metabolites that could be 210 secreted by each microbial community model (cf. Methods), providing thereby a 211 characterisation of the differential microbial metabolic capabilities in PDs and controls. The 212 secretion of nine metabolites had differential NMPCs in PD ( Figure 4A , all FDR<0.05) as 213 determined by multivariable regressions adjusting for age, sex, BMI, and technical covariates. 214 13 cysteine-glycine production and Roseburia for 30% of the variance in uracil production 240 potential. Akkermansia impacted the secretion profiles the most and substantially contributed 241 to the metabolism of nine metabolites ( Figure 4F ), including the neurotransmitter gamma-242 aminobutyric acid (GABA) and two sulphur species, being hydrogen sulphide and methionine. 243 GABA was also significantly altered between PD and controls on a nominal level missing FDR 244 corrected significance narrowly (b=0.18, 95%-CI:(0.06;0.30), p=0.003, FDR=0.0501). These 245 analyses demonstrate the added value of metabolic modelling to investigate altered metabolic 246 functions from the whole microbial composition. 247 248 249
Figure 4: Result of analysing secretion profiles of microbial communities. A. Box plots for 250
NMPCs differential between cases and controls with FDR<0.05. B. NMPCs with sex-specific 251 PD signature or constipation effects (all FDR<0.05). C. Differential age trajectory between 252 cases and controls for cysteine-glycine (p<0.05). D. Association of pantothenic acid with non-253 motor symptoms. E. Genera contributing more than 25% to NMPCs different between cases 254 and controls. F. Akkermansia contribution to community production of 12 metabolites 255 expressed as a percentage of total production for each compound. Metabolites highlighted in 256 In this study, we aimed to elucidate compositional and functional changes in the faecal 262 microbiome of PD patients. Therefore, we analysed 16S rRNA data from a cohort of typical 263 PD patients (n=147) and controls (n=162), and performed personalised microbial 264 computational modelling. We identified i) eight genera and nine species that changed 265 significantly in their relative abundances between PD patients and healthy controls. ii) PD-266 associated microbial patterns that were dependent on sex, age, BMI, constipation, and iii) in 267 PD patients altered secretion potentials, particularly in sulphur metabolism, using metabolic 268 modelling of microbial communities. Overall, our work demonstrated compositional and 269 functional differences in the gut microbial communities of Parkinson's disease patients 270 providing novel experimentally testable hypothesis related to PD pathogenesis. 271
The microbial compositional analyses of our cohort identified significantly different 272 microbial abundance distributions between PD patients and healthy controls (Table 1 ). Up to 273 date, 13 studies have described altered colonic microbial compositions associated with PD and 274 an overall picture starts to arise ( Figure 5 ). For instance, the microbial the families of 275 Verrucomicrobiaceae and Lactobacillaceae have been consistently found to have an increased 276 abundance in PD ( Figure 5 ). In accordance, our study also reports increased abundance in PD 277 of Akkermansia, Christensenella, and Lactobacillus. Similarly, Bifidobacteria has also been 278 repeatedly associated with PD ( Figure 5 ) but in our study, we could show that the 279 Bifidobacteria association dependent on constipation (Figure 3 ) highlighting the need for 280 incorporating disease-specific phenotypes as covariates into the statistical design. between the studies hence highlight the importance of performing meta-analysis to identify 302 global microbial signatures, as it has been done for, e.g., colorectal cancer (Wirbel et al. 2019) . 303
Such meta-analysis may also permit to investigate subgroups of PD, as the number of cases 304 and controls would be substantially increased and thus provide higher statistical power. For 305 instance, we observed various effect modulators that were not reported before in humans (Table  306 1), such as Paraprevotella abundance reduction being specific to women. This result is 307 apparently in contradiction with findings from Bedarf and colleagues (Bedarf et al. 2017) who 308 reported decreased levels of Prevotellaceae in a cohort of only male PD patients. However, 309 once again, differences might be explained by different inclusion criteria, methodologies, and 310 related possible sex-specific effects. Interestingly, a recent study reported a higher abundance 311 of Paraprevotella in male mice compared to female mice (Huang et al. 2018) . Despite the lack 312 of extensive studies on gender-specific differences in microbiome composition, we suggest that 313 machine learning procedures on microbiome data should be performed in a sex-stratified 314 manner. Larger cohorts, e.g., through meta-analysis of published cohorts would allow the 315 identification of generalizable microbial differences in PD patients and also, specific microbial 316 changes associated with certain traits and physiological characteristics, as suggested by our 317 data. 318
We could not detect an effect of the dopaminergic, PD specific medication on the 319 microbiome composition, after correction for multiple testing. Also the fact that key findings 320 from the study of Bedarf and colleagues were reproduced in other cohorts of PD patients under 321 medication, including ours, support that notion. Nonetheless, in previous studies, Dorea and 322 Phascolarctobacterium genera have been negatively associated with levodopa equivalent doses 323 (Qian et al. 2018 ) and members of the family of Bacillaceae have been correlated with 324 levodopa treatment (Heintz-Buschart et al. 2018) . Consequently, it cannot be excluded that 325 medication is associated with microbial changes, albeit the association may be weaker than the 326 effects of other covariates. As PD drugs are often taken in combinations, it would require a 327 larger sample size than used in our study to permit the investigation of all possible drug 328 combinations. The lack of clear association is somewhat expected as levodopa is absorbed in 329 the upper part of the small intestine (Streubel et al. 2006 ) and thus small intestinal rather than 330 large intestinal microbes may play a more prominent role in levodopa bioavailability. 331
Consistently, a recent study showed that bacterial tyrosine decarboxylases restrict the 332 bioavailability of levodopa (van Kessel et al. 2019 (VMH ID: TAURPYRAT). Therefore, an increased production of L-alanine might be due to could then lead to an increased conversion into D-alanine via the alanine racemase (VMH ID: 371 ALAR), which was present in 808/818 gut microbes in the AGORA collection. Accordingly, 372 D-alanine was one of the three metabolite secretion profiles increased in constipated PD 373 patients ( Figure 4E ). This hypothesis of B. wadsworthia playing a role in constipation of PD 374 patients would need to be experimentally validated, especially since we could not find 375 statistically significant changes in the association between the abundance of B. wadsworthia an increase has been consistently reported in PD patients ( Figure 5 ). The A. muciniphila 386 abundance had the largest contribution to the significantly altered metabolite secretion profiles 387 ( Figure 4E ), including the neurotransmitter gamma-aminobutyric acid (GABA). While its 388 predicted secretion potential was only nominally increased in PD patients the present study, 389 higher GABA secretions rates have also been predicted based on microbiome data from early 390 stage levodopa naive PD patients (Hertel et al. in revision) . Importantly, GABA receptors have 391 been found in the enteric nervous system, gut muscle, gut epithelial layers, and endocrine-like 392 cells (Hyland and Cryan 2010) and its gut receptors are thought to be related to gastric motility 393 (peristalsis), gastric emptying, and acid secretion (Hyland and Cryan 2010). Experiments with 394 the GABAb agonist baclofen have shown that GABAb receptors can reduce gastric mobility 395 in the colon of rabbits (via cholinergic modulation) (Tonini et al. 1989) . Interestingly, A. 396 muciniphila has been shown to be positively associated with gastrointestinal transit time 397 (Gobert et al. 2016; Vandeputte et al. 2016) . GABA could reach the CNS via blood stream as 398 a lipophilic compound, being able to pass the blood brain barrier. Additionally, microbial 399 GABA could affect the brain-gut axis by contributing the human GABA pools, especially as it 400 has been shown that the microbiome can affect GABA receptor density in the CNS via the 401 vagus nerve (Bravo et al. 2011) . To establish whether and which role A. muciniphila and GABA 402 may play a role in prodomal PD, further experimental studies will be required. 403
In order to move beyond mere cataloguing of microbial changes associated with 404 diseases, pathway-based tools (Abubucker et al. 2012) analysis with computational modelling to gain insight into potential functional, i.e., metabolic, 411 consequences of changed microbe abundances in PD. The advantage of our approach is that 412 the functional assignments may be more comprehensive than more canonical methods, such as 413 KEGG ontologies because (1) the underlying genome-scale metabolic reconstructions have 414 been assembled based on refined genome annotations and have been manually curated to 415 ensure that the reaction and gene content is consistent with current knowledge about the 416 microbe's physiology, and (2) each of these reconstructions, alone or in combinations, are 417 amenable to metabolic modelling and thus functional and metabolic consequences of a changed simulations are thus allowing to predict functional consequences and not only pathway or 420 reaction enrichment, as typically done. 421 422
Strength and limitation 423
Here, we present microbiome analyses in a large population-based, monocentric case-424 control study on PD from a defined area ( Figure 5 ). Capitalising on the overall clinical spectrum 425 of PD of the LuxPark cohort, which reflects a representative sample of PD patients of different 426 disease stages from a defined geographical area, we demonstrated that microbial composition 427 is not only altered in PD but also that the observed associations of PD with changes in the 428 composition of the microbiome should be interpreted in the context of age, sex, BMI, and 429 constipation. This information is of importance for clinical translation, highlighting the need 430 for both, (i) a personalised and (ii) a holistic approach, to understand the role of microbial 431 communities in PD pathogenesis. In a second step targeting the potential functional changes 432 related to PD-associated microbiomes, we performed metabolic modelling based on the 433 with the host on sulphur metabolism. Hence, metabolic modelling provides a valuable tool for 438 deciphering the metabolic activity of microbial communities in PD. 439 However, despite the partial confirmation of previous results by our study (Table 5) , 440 several limitations should be kept in mind. First, certain covariates were not investigated, such 441 as diet, exercise, and smoking. Whether these covariates alter the PD-specific signature is yet 442 to be analysed. Although our study belongs to the three largest studies performed yet on PD, 443 our sample size was still too small to deliver insights on combinations of drugs. Furthermore, 16S RNA sequencing, as applied in our study, is not allowing analyses on the strain level and 445 may lead to misclassifications (Janda and Abbott 2007), and follow-up studies based on 446 shotgun sequencing are needed to further corroborate our results. However, our results are 447 notably well aligned with a previous shotgun sequencing study (Bedarf et al. 2017) , which 448 would further support a role of 16S RNA sequencing as a cost-efficient screening method. 449
Being cross-sectional in nature, causal inference is not possible. Consequently, although 450 metabolic modelling has been numerous times been shown to correctly predict attributes of 451 Criteria (Hughes et al. 1992 ). Furthermore, we excluded control patients with a United 476 Parkinson's Disease Rating Scale (UPDRS) III score above ten, except for one control where 477 the high UPDRS III score was caused by an arm injury. Furthermore, we excluded control 478 persons who took dopaminergic medications (n=5), and individuals who reported to have taken 479 antibiotics in the last six months (controls: n=20, PD: n=13). Note that excluded observations 480 behave sub-additive, because of overlap between the exclusion criteria (i.e. individuals below 481 age 50 and taking antibiotics). Finally, 309 individuals (controls: n=162, cases: n=147) were 482 included in the statistical analyses. 483
All study participants gave written informed consents, and the study was performed in 484 accordance with the Declaration of Helsinki. The LuxPark study (Hipp et al. 2018 For descriptive statistics, metric variables were described by means and standard 574 deviations, while nominal variables were described by proportions. Missing values were not 575 imputed, and the pattern of missing values was not assessable via the ADA platform (Hipp et 576 al. 2018) . The read counts for each metagenomic feature (e.g., genera and species) were divided 577 by total read counts such that relative abundances were retrieved. Relative abundances were 578 checked for outliers. Observations with more than four standard deviations from the mean were 579 excluded from analyses. Only genera and species detected in more than 50% of all samples 580 were included in the analyses, resulting in 62 genera and 127 species. 581
582
The metagenomic data was analysed using fractional regressions as developed by 583 (Papke and Wooldridge 1996) . Fractional regressions, first applied to econometric problems, 584 are semiparametric methods designed to model fractional data without the need of specifying 585 the distribution of the response variable. Fractional regressions are further inherently robust 586 against heteroscedasticity and can be parametrised in odds ratios, delivering convenient 587 interpretations of the regression coefficients. All statistical models included technical 588 covariates, batch, total read counts, and unclassified read counts (reads for which a taxonomic 589 assignment was not possible independently from any threshold of confidence estimate value 590 used). The read count variables were included into the statistical model, as it has been shown 591 that normalisation by division can introduce bias if certain statistical assumptions implied by 592 the application of division are not fulfilled (Hertel et al. 2018 ). In the case of metagenomic 593 data, the effect of read counts would be removed by division if the observations would be correlate amongst each other, violating the assumptions needed to construct multinomial 596 distributions. In consequence, read count normalisation by division is prone to introduce a bias 597 into metagenomic data; a potential bias, we corrected for by including the read counts as 598 covariates into the model. 599
Before fitting the final statistical models, we explored the associations of basic 600 covariates (age, sex, and BMI) with metagenomic features using fractional regressions as 601 described above to avoid misspecifications of the statistical models. Since the data showed a 602 high range in age and BMI, we checked for potential non-linear associations by including these 603 variables into the models as restricted cubic splines (Harrell 2001) using three knots defined 604 by the 5%-percentile, the median, and the 95%-percentile. As in the case for age, we found 605 species with indications of non-linear age-associations with p<0.01, age was modelled in all 606 analyses via restricted cubic splines. 607 To analyse difference between genus abundances between PD and controls, fractional 614 regressions were carried out with the relative abundance of the genus as the response variable, 615 while including technical covariates, age (restricted cubic splines), sex, and BMI into the 616 statistical modelling. The predictor of interest was the study group indicator variable. We 617 corrected for multiple testing using the Benjamini-Hochberg procedure (Benjamini 2010) by 618 setting the false discovery rate (FDR) to 0.05. Consequently, we corrected for 62 tests when 29 reporting genera results. These analyses were repeated analogously for the taxonomic level of 620 species, while correcting for multiple testing via the FDR. 621
Next, we explored the possibility of statistical interactions between basic covariates 622 (age, sex, and BMI) and the group indicator. For these analyses, we once again modelled age 623 and BMI via restricted cubic splines allowing for non-linear interaction terms. We only tested 624 two-way interaction terms. All interaction terms were introduced simultaneously into the 625 statistical model and tested on significance via a Wald test (Harrell 2001), correcting for 626 multiple testing via the FDR. For the globally significant test, the single interaction terms were 627 investigated to explore which covariate-group interaction contributed to the overall 628 significance. For interpretation, the interaction terms were visually inspected by plotting the 629 predictions conditional on technical covariates. These analyses were then rerun with species 630 abundances as response variable instead of genus abundances. 631
We assessed the influence of constipation on the microbial composition. We introduced 632 the binary predictor constipation (yes/no) as additional predictor into the model and the 633 corresponding group-constipation interaction term. Both terms were tested simultaneously on 634 zero with a Wald test. The analyses were once again adjusted for technical covariates, age 635 (restricted cubic splines), sex, and BMI, and we corrected for multiple testing via the FDR. 636 637
Analyses of within PD phenotypes in relation to microbial composition 638
We investigated the association pattern of medication and clinical features regarding 639 the microbial composition. These analyses were only performed on the IPD cases, while 640 controls were excluded from the analyses. First, we analysed the disease duration as measured 641 in years between the date of the stool sampling and the year of the diagnosis. The analyses were 642 conducted as before via fractional regressions with the genus abundances as the response 643 variable, while adjusting for technical covariates, age (restricted cubic splines), sex, and BMI. symptoms, the non-motor symptoms as measured by the NMS, the Hoehn-Yahr staging of the 646 disease as a global measure of disease progression, and the sniff-score. All these analyses were 647 performed adjusted for technical covariates, age (restricted cubic splines), sex, BMI, and 648 disease duration. Each of these series of regression represents 62 test, which was accounted for 649 using the FDR. The impact of medication was analysed by examining three classes of 650 medication, a) levodopa, b) mono-amino oxidase/catechol-O-methyltransferase inhibitors, and 651 c) dopamine receptor agonists. We generated three corresponding binary phenotypes (intake/no 652 intake) and added these three variables simultaneously to the statistical model determining the 653 significance of this add-on via a Wald test. We then tested each medication-class in separate 654 analyses, strictly correcting for multiple testing via the FDR (186 tests in total). The analyses 655 were performed adjusted for technical covariates, age (restricted cubic splines), sex, BMI, and 656 disease duration. 657 658
Statistical analyses of fluxes 659
The NMPCs were log transformed such that the skewness of the distribution was 660 minimised (Box and Cox 1964) ). This type of transformation was applied because of the very 661 differently skewed distributions of the single NMPCs. Then, outliers were excluded using the 662 4-SD outlier rule as before. Only fluxes with more than 50% non-zero values were retained in 663 analyses. Furthermore, NMPCs with distributions not suitable for statistical analyses (e.g., 664
distributions with a high number of observations with exact the same numerical value) were 665 excluded resulting in 129 NMPCs included into analyses. 666
The NMPCs were analysed with mixed linear regressions including the batch as random 667 effects. Including the batch variable as a random effect has a higher statistical power in 668 comparison to the fixed effect approach, but relies on more restrictive assumptions. We tested 669 the corresponding random effect assumption by Hausman specification tests and found no 670 indications of violations of the Hausman specification test. Note that this possibility to account 671 for batch effects via random effects is not available with fractional regressions where batch 672 effects were corrected via fixed effects. 673
We performed the same analyses as with the metagenomic data, with the sole exception 674 of replacing the fractional regression model with the linear mixed model. In all other aspects, 675 the analyses followed the same scheme. 676 677
Analyses of species contribution to fluxes 678
To investigate the contribution of species and genera, we calculated for all included 679 genera and all analysed fluxes the pairwise correlation and the corresponding variance 680 contribution (the squared correlation). We classified every correlation above 0.5 (equal to 25% 681 of variance contribution) as a strong correlation in accordance with classical classifications of 682 effect size (Cohen 1988 
